Assignee
SMITH HENRY J
US·6 granted patents·23 pending applications·207 citations·filing 1990–2024
Top patents by PatentIndex Score
29 records- 0191US5018450ALuminescent paintball for marking nighttime impactsSMITH HENRY J·Filed 1990·Granted May 28, 1991·127 cites·2 claims
- 0286US10076600B2Targeted apheresis for the treatment of rheumatoid arthritis and immune disordersSMITH HENRY J·Filed 2015·Granted Sep 18, 2018·3 cites·20 claims
- 0385US5001880AMethod for producing luminescent paintballsSMITH HENRY J·Filed 1990·Granted Mar 26, 1991·77 cites·1 claims
- 0462US2025235594A1Targeted apheresis to treat inflammationSMITH HENRY J·Filed 2024·Application pending·0 cites
- 0559US2013330402A1Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseasesSMITH HENRY J·Filed 2013·Application pending·0 cites
- 0656US2013039973A1Viral Immunogenic CompositionsSMITH HENRY J·Filed 2012·Application pending·0 cites
- 0755US12458595B2Thermally stabilized nanoemulsionSMITH HENRY J·Filed 2018·Granted Nov 4, 2025·0 cites·6 claims
- 0855US11806459B2Targeted apheresis to treat preeclampsiaSMITH HENRY J·Filed 2021·Granted Nov 7, 2023·0 cites·11 claims
- 0955US2006018829A1Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatmentSMITH HENRY J·Filed 2004·Application pending·0 cites
- 1054US11590078B2Viral immunogenic compositionsSMITH HENRY J·Filed 2015·Granted Feb 28, 2023·0 cites·2 claims
- 1153US2022280631A1Viral pandemic vaccineSMITH HENRY J·Filed 2021·Application pending·0 cites
- 1252US2021008215A1Optimizing drug deliverySMITH HENRY J·Filed 2019·Application pending·0 cites
- 1351US2007015291A1Rapid test for glycated albumin in bloodSMITH HENRY J·Filed 2006·Application pending·0 cites
- 1451US2014186435A1Soluble tumor necrosis factor receptor (stnf-r) used as a targeting agent to treat arthritis and other diseasesSMITH HENRY J·Filed 2014·Application pending·0 cites
- 1551US2014186434A1Anti-tumor necrosis factor alpha (tnf-a) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY J·Filed 2014·Application pending·0 cites
- 1651US2006111295A1Cellular receptors utilized as carrier agents for pharmaceutical compounds used in the treatment of arthritis, inflammation and immune disordersSMITH HENRY J·Filed 2005·Application pending·0 cites
- 1751US2022008511A1Tumor treatment using cytokines and cancer drugsSMITH HENRY J·Filed 2020·Application pending·0 cites
- 1850US2020262903A1Treatment of age-related macular degenerationSMITH HENRY J·Filed 2019·Application pending·0 cites
- 1950US2019022005A1Multi-Drug Lipsomes to Treat TumorsSMITH HENRY J·Filed 2018·Application pending·0 cites
- 2049US2010247650A1Treatment for pre-eclampsia in pregnant women using targeted apheresisSMITH HENRY J·Filed 2009·Application pending·0 cites
- 2149US2006159680A1Targeted apherisis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2006·Application pending·0 cites
- 2249US2012165781A1Targeted apheresis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2012·Application pending·0 cites
- 2348US2022008636A1Apheresis to remove interfering substancesSMITH HENRY J·Filed 2020·Application pending·0 cites
- 2447US2010298753A1Targeted apheresis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2010·Application pending·0 cites
- 2546US2010098698A1Targeted apheresis for the treatment of rheumatoid arthritisSMITH HENRY J·Filed 2010·Application pending·0 cites
- 2646US2015182632A1Anti-interleukin-1 (il-1) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY J·Filed 2015·Application pending·0 cites
- 2745US2020069861A1Apheresis to reduce high blood pressure in pre-eclampsiaSMITH HENRY J·Filed 2019·Application pending·0 cites
- 2843US2006153835A1Treatment of pre-eclampsia in pregnant women using targeted apheresisSMITH HENRY J·Filed 2006·Application pending·0 cites
- 2942US2006270060A1Rapid test for glycated albumin in salivaSMITH HENRY J·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →